Influence of endogenous glucagon-like peptide-2 on lipid disorders in mice fed a high-fat diet

Endocrine Research

Volumn 41, Issue 4, 2016, Pages 317-324

  Baldassano, Sara ^a   Amato, Antonella ^a   Rappa, Francesca ^a,b   Cappello, Francesco ^a,b   Mulè, Flavia ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Istituto Euro Mediterraneo di Scienza e Tecnologia (IEMEST)   (Italy)

Author keywords

GLP 2; insulin resistance; lipids; liver; obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; FECES LIPID; GLUCAGON LIKE PEPTIDE 2; GLUCAGON RECEPTOR ANTAGONIST; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; GLUCAGON-LIKE PEPTIDE-2 (3-33); LIPID; PEPTIDE FRAGMENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISORDERS OF LIPID METABOLISM; FATTY LIVER; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; INTESTINE ABSORPTION; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; LONG TERM CARE; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; C57BL MOUSE; METABOLIC DISORDER;

ANIMALS; DIET, HIGH-FAT; GLUCAGON-LIKE PEPTIDE 2; LIPIDS; MALE; METABOLIC DISEASES; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS;

EID: 84959037184     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.3109/07435800.2016.1141950     Document Type: Article

References (39)

1. D.J.Drucker, B.Yusta Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Annu Rev Physiol 2014;76:561–83.
2. S.Baldassano, A.Amato GLP-2:what do we know? What are we going to discover? Regul Pep 2014;194: 6–10.
3. P.Janssen, A.Rotondo, F.Mulé, J.Tack A comparison of glucagon-like peptides 1 and 2. Aliment Pharmacol Ther 2013;37:18–36.
4. P.B.Jeppesen, M.Pertkiewicz, B.Messing, et al. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology 2012;143:1473–81.
5. S.Baldassano, A.L.Bellanca, R.Serio, F.Mulè Food intake in lean and obese mice after peripheral administration of glucagon-like peptide 2. J Endocrinol 2012;213:277–84.
6. M.Tang-Christensen, P.J.Larsen, J.Thulesen, et al. The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nat Med 2000;6:802–07.
7. A.Amato, S.Baldassano, R.Serio, F.Mule` Glucagon-like peptide-2 relaxes mouse stomach through vasoactive intestinal peptide release. Am J Physiol Gastrointest Liver Physiol 2009;296:G678–84.
8. A.Amato, A.Rotondo, L.Cinci, et al. Role of cholinergic neurons in the motor effects of glucagon-like peptide-2 in mouse colon. Am J Physiol Gastrointest Liver Physiol 2010;299:G1038–44.
9. A.Rotondo, A.Amato, S.Baldassano, et al. Gastric relaxation induced by glucagon-like peptide-2 in mice fed a high-fat diet or fasted. Peptides 2011;32:1587–92.
10. S.Baldassano, S.Liu, M.H.Qu, et al. Glucagon-like peptide-2 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro. Am J Physiol Gastrointest Liver Physiol 2009;297:G800–05.
11. D.G.Munroe, A.K.Gupta, P.Kooshesh, et al. Prototypic G protein–coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc Natl Acad Sci 1999;96:1569–73.
12. T.Angelone, E.Filice, A.M.Quintieri, et al. Receptor identification and physiological characterization of glucagon-like peptide-2 in the rat heart. Nutr Metab Cardiovasc Dis 2012;22:486–94.
13. N.El-Jamal, E.Erdual, M.Neunlist, et al. Glucagon-like peptide-2:broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration. Am J Physiol Gastrointest Liver Physiol 2014;307:G274–85.
14. P.D.Cani, S.Possemiers, T.Van de Wiele, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009;58:1091–1103.
15. J.Bahrami, C.Longuet, L.L.Baggio, et al. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse. Gastroenterology 2010;139:857–68.
16. S.Baldassano, A.Amato, F.Cappello, et al. Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet. J Endocrinol 2013;217:11–20.
17. S.Baldassano, F.Rappa, A.Amato, et al. GLP-2 involvement as a beneficial factor in the glucose homeostasis in mice fed a high fat diet. J Cell Physiol 2015;230:3029–36.
18. J.Hsieh, C.Longuet, A.Maida, et al. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. Gastroenterology 2009;137:997–1005.
19. J.J.Meier, M.A.Nauck, A.Pott, et al. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology 2006;130:44–54.
20. S.Dash, C.Xiao, C.Morgantini, et al. Glucagon-like peptide 2 regulates release of chylomicron from the intestine. Gastroenterology 2014;2:1–10.
21. G.J.Hein, C.Baker, J.Hsieh, et al. GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production:evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states. Diabetes 2013;62:373–81.
22. M.Jaiswal, A.Schinske, R.Pop-Busui Lipids and lipid management in diabetes. Best Pract Res Clin Endocrinol Metab 2014;28:325–38.
23. D.Nuzzo, P.Picone, S.Baldassano, et al. Insulin resistance as common molecular denominator linking obesity to Alzheimer’s disease. Curr Alzheimer Res 2015;12:723–35.
24. V.Petit, L.Arnould, P.Martin, et al. Chronic high-fat diet affects intestinal fat absorption and postprandial triglyceride levels in the mouse. J Lipid Res 2007;48:278–87.
25. J.Folch, M.Lees, G.H.Sloane Stanley A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497–509.
26. J.C.Fraulob, R.Ogg-Diamantino, C.Fernandes-Santos, et al. Mouse model of metabolic syndrome:insulin resistance, fatty liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 2010;46:212–23.
27. V.E.de Meijer, H.D.Le, J.A.Meisel, et al. Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model. Metabolism 2010;59:1092–1105.
28. S.1.Nishikawa, J.Sugimoto, M.Okada, et al. Gene expression in livers of BALB/C and C57BL/6J mice fed a high-fat diet. Toxicol Pathol 2012;40: 71–82.
29. D.W.Nelson, J.W.Sharp, M.S.Brownfield, et al. Localization and activation of glucagon-like peptide-2 receptors on vagal afferents in the rat. Endocrinology 2007;148:1954–62.
30. E.D.Shin, J.L.Estall, A.Izzo, et al. Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice. Gastroenterology 2005;128:1340–53.
31. H.N.Ginsberg, Y.L.Zhang, A.Hernandez-Ono Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 2005;36:232–40.
32. J.Hsieh, A.A.Hayashi, J.Webb, K.Adeli Postprandial dyslipidemia in insulin resistance:mechanisms and role of intestinal insulin sensitivity. Atheroscler Suppl 2008;9:7–13.
33. N.A.Abumrad, N.O.Davidson Role of the gut in lipid homeostasis. Physiol Rev 2012;92:1061–85.
34. J.M.Dietschy, S.D.Turley, D.K.Spady Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res 1993;34:1637–59.
35. M.Asrih, F.R.Jornayvaz Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol 2013;218:R25–36.
36. L.Cinci, M.S.Faussone-Pellegrini, A.Rotondo, et al. GLP-2 receptor expression in excitatory and inhibitory enteric neurons and its role in mouse duodenum contractility. Neurogastroenterol Motil 2011;23:e383–92.
37. X.Guan, H.E.Karpen, J.Stephens, et al. GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology 2006;130:150–64.
38. P.Brun, I.Castagliuolo, V.Di Leo, et al. Increased intestinal permeability in obese mice:new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007;292:G518–25.
39. B.A.Moore, N.Peffer, A.Pirone, et al. GLP-2 receptor agonism ameliorates inflammation and gastrointestinal stasis in murine postoperative ileus. J Pharmacol Exp Therap 2010;333:574–83.